(University of Helsinki) In the new study, the authors aimed to reprogram rapamycin by keeping the parts of rapamycin and tacrolimus that bind FKBP12 and changing the remaining half of the molecule in order to target completely new disease-associated proteins beyond mTOR and calcineurin.
from EurekAlert! - Technology, Engineering and Computer Science https://ift.tt/2SrkbGt
Thursday, February 28, 2019
Reprogramming the wonder drug rapamycin allows creation of new small-molecule drugs
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.